Penumbra spikes after Stryker- Inari deal
After the MedTech giant Stryker (NYSE:SYK) agreed to offer $4.9B in cash to acquire Inari Medical (NASDAQ:NARI), a maker of clot removal systems, shares of its rival Penumbra (NYSE:PEN) gained sharply ...
Zacks.com on MSN21d
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...
Benzinga.com1mon
Demystifying Inari Medical: Insights From 6 Analyst Reviews
Inari Medical Inc is a medical device company ... vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism ...
Inari Medical (NASDAQ:NARI) Price Target Raised to $80.00
Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a ...
Nasdaq1mon
Oppenheimer Initiates Coverage of Inari Medical (NARI) with Outperform Recommendation
Inari Medical Background Information (This ... FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for ...